Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BERNARD TAWFIK

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1396035556
CMS profile
1057783
Location
ALBUQUERQUE, NM

General Payments · PY2018–2024

$4,165.46

  • Reported across 41 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,714.48

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,364.48 16
Grant $350.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $18.42 1
PY2019 $121.76 2
PY2020 $175.00 1
PY2021 $605.21 4
PY2022 $777.30 8
PY2023 $753.29 8
PY2024 $1,714.48 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $350.00 01/02/2024 Grant Undisputed 01/23/2026 1104750480 CMS
AstraZeneca Pharmaceuticals LP $112.23 06/11/2024 Food and Beverage Undisputed 01/23/2026 1105535836 CMS
AstraZeneca Pharmaceuticals LP $128.92 07/25/2024 Food and Beverage Undisputed 01/23/2026 1105206989 CMS
AstraZeneca Pharmaceuticals LP $176.40 12/12/2024 Food and Beverage Undisputed 01/23/2026 1104440783 CMS
AstraZeneca Pharmaceuticals LP $132.80 12/14/2024 Food and Beverage Undisputed 01/23/2026 1104672743 CMS
Daiichi Sankyo Inc. $128.44 10/10/2024 Food and Beverage Undisputed 01/23/2026 1089489312 CMS
Eisai Inc. $34.21 12/13/2024 Food and Beverage Undisputed 01/23/2026 1110733412 CMS
Gilead Sciences, Inc. $50.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 1133804338 CMS
Gilead Sciences, Inc. $60.00 07/22/2024 Food and Beverage Undisputed 01/23/2026 1133804340 CMS
Gilead Sciences, Inc. $65.90 10/25/2024 Food and Beverage Undisputed 01/23/2026 1133804342 CMS
Gilead Sciences, Inc. $119.97 11/07/2024 Food and Beverage Undisputed 01/23/2026 1133804344 CMS
Ipsen Biopharmaceuticals, Inc $88.69 04/24/2024 Food and Beverage Undisputed 01/23/2026 1091963213 CMS
Merck Sharp & Dohme LLC $44.81 07/26/2024 Food and Beverage Undisputed 01/23/2026 1141760241 CMS
Novartis Pharmaceuticals Corporation $75.00 04/05/2024 Food and Beverage Undisputed 01/23/2026 1087417276 CMS
Novartis Pharmaceuticals Corporation $62.92 09/10/2024 Food and Beverage Undisputed 01/23/2026 1087417278 CMS
Novartis Pharmaceuticals Corporation $7.93 09/19/2024 Food and Beverage Undisputed 01/23/2026 1087417280 CMS
Stemline Therapeutics Inc. $76.26 12/13/2024 Food and Beverage Undisputed 01/23/2026 1142958626 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.